Back to Career News

Bharat Bio begins first phase of human clinical trials

July 15, 2020

Bharat Bio begins first phase of human clinical trials

Bharat Biotech has begun the principal period of human clinical preliminaries for India’s first Covid-19 antibody competitor Covaxin. Covaxin is being created by Hyderabad-based Bharat Biotech in a joint effort with the Indian Council of Medical Research’s Pune-based National Institute of Virology.

Volunteers at 14 areas across India are experiencing what is named as “wellbeing and screening” study to check all boundaries, including contaminations, liver capacities, and conceivable introduction to Covid-19 or comparative irresistible infections.

A senior ICMR official told ET, “After an all-reasonable, the subjects would be given what we call a naive status. This would imply that they can be managed small doses of the vaccine”.

Recommended for you ...

Axis Bank and Mastercard Launch Premium Credit Card for Small Business Owners
Axis Bank and Mastercard Launch Premium Credit Card for Small Business Owners

September 26, 2024

Banks Report Over 15% Growth in New Credit Card Additions: RBI Data
Banks Report Over 15% Growth in New Credit Card Additions: RBI Data

September 26, 2024

National Company Law Tribunal (NCLT) Approves Merger of IDFC and IDFC First Bank
National Company Law Tribunal (NCLT) Approves Merger of IDFC and IDFC First Bank

September 25, 2024

Chat on WhatsApp